Aesculap AG

Aesculap AG specialises in reusable surgical instruments and spinal fixation systems. Their portfolio includes spinal bone screws (non-bioabsorbable), bone-screw internal spinal fixation connectors, suturing needle holders, general-purpose surgical scissors, bone curettes, and manual endodontic files/rasps. They also produce systems for plume evacuation during surgery, such as the PLASMAFIT tube. These devices are designed for orthopaedic, spinal, and general surgical procedures.

Aesculap AG is headquartered in Germany, which places its devices under the scope of the EU Medical Device Regulations (MDR). Since the company manufactures devices listed in eudamed—the EU’s centralised registry for medical devices—they must comply with MDR requirements for classification, registration, and post-market surveillance. The MDR categorises their products as Class I, Class IIa, or Class IIb based on risk, ensuring appropriate regulatory oversight.

Aesculap AG’s devices are registered in eudamed, the European database for medical devices. This registry is critical because it provides transparent, publicly accessible information about the manufacturer, device details, and regulatory status under the EU MDR. Listing in eudamed ensures traceability, supports market surveillance, and helps healthcare professionals verify device compliance before use.

Aesculap AG’s devices fall into Class I, Class IIa, or Class IIb under the EU MDR, determined by their risk level. Class I devices (e.g., reusable scissors or curettes) pose the lowest risk and require basic compliance measures like general safety requirements. Class IIa (e.g., some spinal connectors) and Class IIb (e.g., specialised fixation systems like S4®) involve higher risks, necessitating additional clinical evaluations, technical documentation, and post-market monitoring to ensure safety and performance.

Healthcare providers may verify a device’s presence in eudamed to confirm its legal status, manufacturer details, and classification under EU MDR. This helps ensure the device is authorised for use, supports informed decision-making, and aligns with hospital procurement policies. For example, Class IIb devices like the SecureSpan® spinal system require stricter scrutiny, so eudamed provides essential transparency to validate compliance before clinical application.